Cargando…
Hypercoagulability and Inflammatory Markers in a Case of Congenital Thrombotic Thrombocytopenic Purpura Complicated by Fetal Demise
Background: Congenital thrombotic thrombocytopenic purpura (cTTP) is a rare disorder caused by an inherited genetic deficiency of ADAMTS13 and affects less than one per million individuals. Patients who are diagnosed with TTP during pregnancy are at increased risk of maternal and fetal complications...
Autores principales: | Skeith, Leslie, Hurd, Kelle, Chaturvedi, Shruti, Chow, Lorraine, Nicholas, Joshua, Lee, Adrienne, Young, Daniel, Goodyear, Dawn, Soucie, Jennifer, Girard, Louis, Dufour, Antoine, Agbani, Ejaife O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737388/ https://www.ncbi.nlm.nih.gov/pubmed/36498688 http://dx.doi.org/10.3390/jcm11237115 |
Ejemplares similares
-
Preeclampsia: Platelet procoagulant membrane dynamics and critical biomarkers
por: Agbani, Ejaife O., et al.
Publicado: (2023) -
Immune thrombotic thrombocytopenic purpura: Spotlight on long-term outcomes and survivorship
por: Selvakumar, Sruthi, et al.
Publicado: (2023) -
Thrombotic thrombocytopenic purpura
por: Knöbl, Paul
Publicado: (2018) -
Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry
por: Agosti, Pasquale, et al.
Publicado: (2023) -
Thrombotic Thrombocytopenic Purpura and Gemcitabine
por: Kasi, Pashtoon Murtaza
Publicado: (2011)